The Copper T380A IUD vs. Oral Levonorgestrel for Emergency Contraception

All women presenting to 2 Planned Parenthood Association of Utah clinics in Salt Lake City will be offered participation in this study. Women will select either the copper IUD or oral levonorgestrel for EC. The primary outcome is unplanned pregnancy in the year following presentation for EC.

Secondary outcomes include use of an effective method of contraception over the next year, abortions, repeat use of EC, number of days to first bleeding episode and duration of that bleeding episode, use of a barrier method to prevent sexually transmitted infections, patient satisfaction with the chosen method of EC and contraception. Participants selecting the IUD will be assessed for IUD expulsion, perforation, and removal.

Inclusion criteria

• Women 18-30 years old,
• in need of emergency contraception (had unprotected intercourse within 120 hours),
• willing to give consent for participation in research,
• willing to comply with study requirements, and
• accessible by telephone.

Participants selecting the IUD need to identify themselves as desiring long-term contraception.

Exclusion criteria

• Current pregnancy
• Had pelvic inflammatory disease or septic abortion within the past 3 months or had gonorrhea or chlamydia infection in the last 60 days
• Current behavior suggesting a high risk for pelvic inflammatory disease
• Allergy to copper or Wilson's disease (for participants selecting the copper IUD) or allergy to levonorgestrel (for participants selecting oral levonorgestrel)
• Abnormalities of the uterus that distort the uterine cavity
• Mucopurulent cervicitis
• A previously placed IUD that has not been removed
• Genital bleeding of an unknown etiology
• Ovarian, cervical, or endometrial cancer
• Small uterine cavity (< 6cm)